Chapter 1: A General Framework for Regulatory Intelligence in Medical Product Research and Development
10 Regulatory Affairs Professionals Society
References
1 Regulatory Affairs Professionals Society. RAPS Regulatory Intelligence
Conference. Accessed 17 November 2025. https://regintel2025.
eventscribe.net/
2 Regulatory Affairs Professionals Society. Home page. Accessed 17
November 2025. https://www.raps.org/
3 DIA. Home page. Accessed 17 November 2025. https://www.diaglobal.
org/
4 The Organisation for Professionals in Regulatory Affairs. Home.
Accessed 17 November 2025. https://www.topra.org/
5 International Council for Harmonisation of Technical Requirements for
Pharmaceuticals for Human Use. Home page. Accessed 17 November
2025. https://ich.org/
6 International Council for Harmonisation of Technical Requirements
for Pharmaceuticals for Human Use. Quality guidelines. Accessed 17
November 2025. https://ich.org/page/quality-guidelines
Conclusion
RI goes beyond simply gathering and sharing information.
It is a strategic skill that brings together people, processes,
and technology to enhance the development, approval, and
maintenance of medical products. By observing the regula‑
tory landscape, communicating insights effectively, evaluating
their impact, and acting decisively, organizations create a
cycle of ongoing learning and better decision making.
This framework provides a starting point for that cycle. It
helps organize different activities and provides professionals
in regulatory affairs with a common way to discuss their RI
work. When used thoughtfully, it turns scattered observations
into coordinated strategies that support innovation and help
deliver medicines to the patients who need them.
As new technologies, faster review processes, and more
global collaboration shape the regulatory environment, strong
RI programs will become even more important. This frame‑
work serves as a starting point – a flexible, practical model
that you can adjust to fit your team’s goals and situation.
In the chapters that follow, we will explore elements of
this framework in greater depth. We will examine methods,
tools, and case studies that bring RI to life. By mastering
these principles, we strengthen our collective ability to deliver
safe, effective, and innovative products to patients worldwide.
10 Regulatory Affairs Professionals Society
References
1 Regulatory Affairs Professionals Society. RAPS Regulatory Intelligence
Conference. Accessed 17 November 2025. https://regintel2025.
eventscribe.net/
2 Regulatory Affairs Professionals Society. Home page. Accessed 17
November 2025. https://www.raps.org/
3 DIA. Home page. Accessed 17 November 2025. https://www.diaglobal.
org/
4 The Organisation for Professionals in Regulatory Affairs. Home.
Accessed 17 November 2025. https://www.topra.org/
5 International Council for Harmonisation of Technical Requirements for
Pharmaceuticals for Human Use. Home page. Accessed 17 November
2025. https://ich.org/
6 International Council for Harmonisation of Technical Requirements
for Pharmaceuticals for Human Use. Quality guidelines. Accessed 17
November 2025. https://ich.org/page/quality-guidelines
Conclusion
RI goes beyond simply gathering and sharing information.
It is a strategic skill that brings together people, processes,
and technology to enhance the development, approval, and
maintenance of medical products. By observing the regula‑
tory landscape, communicating insights effectively, evaluating
their impact, and acting decisively, organizations create a
cycle of ongoing learning and better decision making.
This framework provides a starting point for that cycle. It
helps organize different activities and provides professionals
in regulatory affairs with a common way to discuss their RI
work. When used thoughtfully, it turns scattered observations
into coordinated strategies that support innovation and help
deliver medicines to the patients who need them.
As new technologies, faster review processes, and more
global collaboration shape the regulatory environment, strong
RI programs will become even more important. This frame‑
work serves as a starting point – a flexible, practical model
that you can adjust to fit your team’s goals and situation.
In the chapters that follow, we will explore elements of
this framework in greater depth. We will examine methods,
tools, and case studies that bring RI to life. By mastering
these principles, we strengthen our collective ability to deliver
safe, effective, and innovative products to patients worldwide.